Emerging Tools for Stroke Prevention in Atrial Fibrillation

被引：12
作者：
Voukalis, Christos [1 ]
Lip, Gregory Y. H. [1 ]
Shantsila, Eduard [1 ]
机构：
[1] Univ Birmingham, City Hosp, Inst Cardiovasc Sci, Birmingham B18 7QH, W Midlands, England
来源：
EBIOMEDICINE | 2016年 / 4卷
关键词：
Atrial fibrillation; Stroke prevention; Risk stratification; Oral anticoagulation; Non-vitamin K oral anticoagulants; Net clinical benefit; ACUTE ISCHEMIC-STROKE; NET CLINICAL BENEFIT; RISK STRATIFICATION SCHEMES; HEART RHYTHM ASSOCIATION; MOLECULAR-WEIGHT HEPARIN; CARDIOLOGY WORKING GROUP; VITAMIN-K ANTAGONISTS; HAS-BLED SCORE; FIBRIN D-DIMER; ANTITHROMBOTIC THERAPY;
D O I：
10.1016/j.ebiom.2016.01.017
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Ischaemic strokes resulting from atrial fibrillation (AF) constitute a devastating condition for patients and their carerswith huge burden on health care systems. Prophylactic treatment against systemic embolization and ischaemic strokes is the cornerstone for the management of AF. Effective stroke prevention requires the use of the vitamin K antagonists or non-vitamin K oral anticoagulants (NOACs). This article summarises the latest developments in the field of stroke prevention in AF and aims to assist physicians with the choice of oral anticoagulant for patients with non-valvular AF with different risk factor profile. (C) 2016 The Authors. Published by Elsevier B.V. This is an open access article under the CC-BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
引用
收藏
页码：26 / 39
页数：14
相关论文
共 132 条
  • [31] Uninterrupted rivaroxaban vs. uninterrupted vitamin K antagonists for catheter ablation in non-valvular atrial fibrillation
    Cappato, Riccardo
    Marchlinski, Francis E.
    Hohnloser, Stefan H.
    Naccarelli, Gerald V.
    Xiang, Jim
    Wilber, David J.
    Ma, Chang-Sheng
    Hess, Susanne
    Wells, Darryl S.
    Juang, George
    Vijgen, Johan
    Huegl, Burkhard J.
    Balasubramaniam, Richard
    De Chillou, Christian
    Davies, D. Wyn
    Fields, L. Eugene
    Natale, Andrea
    [J]. EUROPEAN HEART JOURNAL, 2015, 36 (28) : 1805 - 1811
  • [32] Dabigatran and Rivaroxaban Use in Atrial Fibrillation Patients on Hemodialysis
    Chan, Kevin E.
    Edelman, Elazer R.
    Wenger, Julia B.
    Thadhani, Ravi I.
    Maddux, Franklin W.
    [J]. CIRCULATION, 2015, 131 (11) : 972 - 979
  • [33] Atrial fibrillation and the hypercoagulable state: From basic science to clinical practice
    Choudhury, A
    Lip, GYH
    [J]. PATHOPHYSIOLOGY OF HAEMOSTASIS AND THROMBOSIS, 2003, 33 (5-6) : 282 - 289
  • [34] Apixaban in Patients with Atrial Fibrillation
    Connolly, Stuart J.
    Eikelboom, John
    Joyner, Campbell
    Diener, Hans-Christoph
    Hart, Robert
    Golitsyn, Sergey
    Flaker, Greg
    Avezum, Alvaro
    Hohnloser, Stefan H.
    Diaz, Rafael
    Talajic, Mario
    Zhu, Jun
    Pais, Prem
    Budaj, Andrzej
    Parkhomenko, Alexander
    Jansky, Petr
    Commerford, Patrick
    Tan, Ru San
    Sim, Kui-Hian
    Lewis, Basil S.
    Van Mieghem, Walter
    Lip, Gregory Y. H.
    Kim, Jae Hyung
    Lanas-Zanetti, Fernando
    Gonzalez-Hermosillo, Antonio
    Dans, Antonio L.
    Munawar, Muhammad
    O'Donnell, Martin
    Lawrence, John
    Lewis, Gayle
    Afzal, Rizwan
    Yusuf, Salim
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2011, 364 (09) : 806 - 817
  • [35] Dabigatran versus Warfarin in Patients with Atrial Fibrillation.
    Connolly, Stuart J.
    Ezekowitz, Michael D.
    Yusuf, Salim
    Eikelboom, John
    Oldgren, Jonas
    Parekh, Amit
    Pogue, Janice
    Reilly, Paul A.
    Themeles, Ellison
    Varrone, Jeanne
    Wang, Susan
    Alings, Marco
    Xavier, Denis
    Zhu, Jun
    Diaz, Rafael
    Lewis, Basil S.
    Darius, Harald
    Diener, Hans-Christoph
    Joyner, Campbell D.
    Wallentin, Lars
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2009, 361 (12) : 1139 - 1151
  • [36] Vitamin K antagonists in heart disease: Current status and perspectives (Section III)
    De Caterina, Raffaele
    Husted, Steen
    Wallentin, Lars
    Andreotti, Felicita
    Arnesen, Harald
    Bachmann, Fedor
    Baigent, Colin
    Huber, Kurt
    Jespersen, Jorgen
    Kristensen, Steen Dalby
    Lip, Gregory Y. H.
    Morais, Joao
    Rasmussen, Lars Hvilsted
    Siegbahn, Agneta
    Verheugt, Freek W. A.
    Weitz, Jeffrey I.
    [J]. THROMBOSIS AND HAEMOSTASIS, 2013, 110 (06) : 1087 - 1107
  • [37] Intravenous alteplase for stroke - Beyond the guidelines and in particular clinical situations
    De Keyser, Jacques
    Gdovinova, Zuzana
    Uyttenboogaart, Maarten
    Vroomen, Patrick C.
    Luijckx, Gert Jan
    [J]. STROKE, 2007, 38 (09) : 2612 - 2618
  • [38] Use of clopidogrel with or without aspirin in patients taking oral anticoagulant therapy and undergoing percutaneous coronary intervention: an open-label, randomised, controlled trial
    Dewilde, Willem J. M.
    Oirbans, Tom
    Verheugt, Freek W. A.
    Kelder, Johannes C.
    De Smet, Bart J. G. L.
    Herrman, Jean-Paul
    Adriaenssens, Tom
    Vrolix, Mathias
    Heestermans, Antonius A. C. M.
    Vis, Marije M.
    Tijsen, Jan G. P.
    van 't Hof, Arnoud W.
    ten Berg, Jurrien M.
    [J]. LANCET, 2013, 381 (9872) : 1107 - 1115
  • [39] Periprocedural Stroke and Bleeding Complications in Patients Undergoing Catheter Ablation of Atrial Fibrillation With Different Anticoagulation Management Results From the Role of Coumadin in Preventing Thromboembolism in Atrial Fibrillation (AF) Patients Undergoing Catheter Ablation (COMPARE) Randomized Trial
    Di Biase, Luigi
    Burkhardt, J. David
    Santangeli, Pasquale
    Mohanty, Prasant
    Sanchez, Javier E.
    Horton, Rodney
    Gallinghouse, G. Joseph
    Themistoclakis, Sakis
    Rossillo, Antonio
    Lakkireddy, Dhanunjaya
    Reddy, Madhu
    Hao, Steven
    Hongo, Richard
    Beheiry, Salwa
    Zagrodzky, Jason
    Rong, Bai
    Mohanty, Sanghamitra
    Elayi, Claude S.
    Forleo, Giovanni
    Pelargonio, Gemma
    Narducci, Maria Lucia
    Dello Russo, Antonio
    Casella, Michela
    Fassini, Gaetano
    Tondo, Claudio
    Schweikert, Robert A.
    Natale, Andrea
    [J]. CIRCULATION, 2014, 129 (25) : 2638 - 2644
  • [40] Diener HC, 2010, LANCET NEUROL, V9, P1157, DOI 10.1016/S1474-4422(10)70274-X
12345678910